- The report contains detailed information about Bionomics Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Bionomics Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Bionomics Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Bionomics Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Bionomics Ltd. business.
About Bionomics Ltd.
Bionomics Limited engages in the discovery and development of therapeutics in the areas of cancer, multiple sclerosis, anxiety, and epilepsy in Australia and France.
MultiCore technology is a suite of methods for the chemical synthesis of complex drug-like molecules with ring structures that is the structure of many marketed drugs, and naturally occurring bioactive molecules. The company applies its MultiCore technology to the production of compound libraries in this complex molecular space that focus on the target of interest and are weighted towards drug-like characteristics.
Angene: Proprietary technology behind BNC105
The companys drug discovery platform Angene incorporates a variety of tools and models of angiogenesis (the formation of new blood vessels) for drug target validation and drug discovery in cancer and inflammation.
IonX is an integrated platform of genomics discoveries and technologies that serves as the foundation for Bionomics' CNS drug discovery and development activities. IonX includes systems for high throughput electrophysiology for early, high content evaluation of drug hits.
Bionomics Merck Serono partnership: Bionomics Merck Serono partnership is a fully funded collaboration, covered by an R&D and licensing agreement. The collaboration represents the validation of Bionomics chemistry platform, Multicore, and know how in ion-channel biology, covered by the companys IonX technology. Bionomics subsidiary Neurofit is also active in the collaboration with Merck Serono. The partnership involves the preclinical development of Kv1.3 as a target for the treatment of multiple sclerosis.
Cancer Therapeutics Co-operative Research Centre: The company is a participant and shareholder of the Cancer Therapeutics Co-operative Research Centre (CTx). CTx is focused on the discovery and early development of small molecule drugs for the treatment of cancer. CTx has a specific focus on small molecule cancer drugs or enabling therapeutics for single or co-therapy regimes.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. BIONOMICS LTD. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. BIONOMICS LTD. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. BIONOMICS LTD. SWOT ANALYSIS
4. BIONOMICS LTD. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. BIONOMICS LTD. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Bionomics Ltd. Direct Competitors
5.2. Comparison of Bionomics Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of Bionomics Ltd. and Direct Competitors Stock Charts
5.4. Bionomics Ltd. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Bionomics Ltd. Industry Position Analysis
6. BIONOMICS LTD. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. BIONOMICS LTD. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. BIONOMICS LTD. ENHANCED SWOT ANALYSIS2
9. AUSTRALIA PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. BIONOMICS LTD. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. BIONOMICS LTD. PORTER FIVE FORCES ANALYSIS2
12. BIONOMICS LTD. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Bionomics Ltd. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Bionomics Ltd. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Bionomics Ltd. Major Shareholders
Bionomics Ltd. History
Bionomics Ltd. Products
Revenues by Segment
Revenues by Region
Bionomics Ltd. Offices and Representations
Bionomics Ltd. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Bionomics Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Bionomics Ltd. Capital Market Snapshot
Bionomics Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Bionomics Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Bionomics Ltd. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Bionomics Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Bionomics Ltd. 1-year Stock Charts
Bionomics Ltd. 5-year Stock Charts
Bionomics Ltd. vs. Main Indexes 1-year Stock Chart
Bionomics Ltd. vs. Direct Competitors 1-year Stock Charts
Bionomics Ltd. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?